Literature DB >> 15953459

Novel mutation in RLBP1 gene in a Japanese patient with retinitis punctata albescens.

Makoto Nakamura1, Jian Lin, Yasuki Ito, Yozo Miyake.   

Abstract

PURPOSE: To report a novel mutation in the RLBP1 gene and optical coherence tomographic findings in a Japanese patient with retinitis punctata albescens.
DESIGN: Observational case report.
METHODS: The RLBP1 gene was analyzed by direct genomic sequencing. A complete ophthalmologic examination was performed.
RESULTS: Compound heterozygous mutations in the RLBP1 gene were identified in the patient. The mutations were a novel missense Arg103Trp mutation and a missense Arg234Trp mutation, the causative mutation of Bothnia dystrophy. The patient's fundi showed numerous white dots with diffuse retinal mottling and bilateral macular degeneration. Her visual function deteriorated progressively during 12-year follow-up. Optical coherence tomography demonstrated decreased retinal thickness, especially the photoreceptor layer.
CONCLUSION: A novel mutation in RLBP1 gene was found in a Japanese patient with retinitis punctata albescens. Degenerative changes of the outer retina were detected by optical coherence tomography.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15953459     DOI: 10.1016/j.ajo.2004.12.011

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  9 in total

1.  Repeatability of mesopic visual acuity measurements using high- and low-contrast ETDRS letter charts.

Authors:  Ana Barrio; Beatriz Antona; María C Puell
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-12-09       Impact factor: 3.117

2.  Mutations in RLBP1 associated with fundus albipunctatus in consanguineous Pakistani families.

Authors:  Shagufta Naz; Shahbaz Ali; S Amer Riazuddin; Tahir Farooq; Nadeem H Butt; Ahmad U Zafar; Shaheen N Khan; Tayyab Husnain; Ian M Macdonald; Paul A Sieving; J Fielding Hejtmancik; Sheikh Riazuddin
Journal:  Br J Ophthalmol       Date:  2011-03-28       Impact factor: 4.638

3.  Bothnia dystrophy is caused by domino-like rearrangements in cellular retinaldehyde-binding protein mutant R234W.

Authors:  Xiaoqin He; Joel Lobsiger; Achim Stocker
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-21       Impact factor: 11.205

4.  Diagnosis in a patient with fundus albipunctatus and atypical fundus changes.

Authors:  Manal Hajali; Gerald A Fishman; Thaddeus P Dryja; Meredith O Sweeney; Martin Lindeman
Journal:  Doc Ophthalmol       Date:  2008-10-24       Impact factor: 2.379

5.  A multimodal study and management of retinitis punctata albescens.

Authors:  Glenda Espinosa-Barberi; José Francisco Galván González; David Viera Peláez
Journal:  Rom J Ophthalmol       Date:  2020 Apr-Jun

6.  Retinitis Punctata Albescens and RLBP1-Allied Phenotypes: Phenotype-Genotype Correlation and Natural History in the Aim of Gene Therapy.

Authors:  Béatrice Bocquet; Hicham El Alami Trebki; Anne Françoise Roux; Gilles Labesse; Philippe Brabet; Carl Arndt; Xavier Zanlonghi; Sabine Defoort-Dhellemmes; Dalil Hamroun; Céline Boulicot-Séguin; Léopoldine Lequeux; Marie Christine Picot; Hélèna Huguet; Isabelle Audo; Claire Marie Dhaenens; Vasiliki Kalatzis; Isabelle Meunier
Journal:  Ophthalmol Sci       Date:  2021-08-17

7.  Loss of function of myosin chaperones triggers Hsf1-mediated transcriptional response in skeletal muscle cells.

Authors:  Christelle Etard; Olivier Armant; Urmas Roostalu; Victor Gourain; Marco Ferg; Uwe Strähle
Journal:  Genome Biol       Date:  2015-12-03       Impact factor: 13.583

8.  Clinical particularities in an atypical case of retinitis pigmentosa.

Authors:  Stanca T Horia; Tabacaru Bogdana; Elena Suvac
Journal:  Rom J Ophthalmol       Date:  2016 Jan-Mar

9.  Qualitative Interviews to Better Understand the Patient Experience and Evaluate Patient-Reported Outcomes (PRO) in RLBP1 Retinitis Pigmentosa (RLBP1 RP).

Authors:  Jane Green; Chloe Tolley; Sarah Bentley; Rob Arbuckle; Marie Burstedt; James Whelan; Karen Holopigian; Kali Stasi; Brigitte Sloesen; Claudio Spera; Jean-Yves Deslandes; Anmol Mullins
Journal:  Adv Ther       Date:  2020-05-05       Impact factor: 3.845

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.